Metraipolis › archive › dc_65bcfe0857e4
Personalizing Maintenance Rituximab in Follicular Lymphoma: A Machine Learning Framework for Risk-Benefit Optimization — Europe PMC PMID:42591699
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42591699
- DOI
- 10.34133/hds.0467
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T16:00:46.162Z
- SHA-256 of the archived text
71cb173501fe3f03fbec58c35f3cd2b52aa3acea93addd36a1f162949aa45305- Stable URL of this page
https://metraipolis.com/documento/dc_65bcfe0857e4
How to cite
Personalizing Maintenance Rituximab in Follicular Lymphoma: A Machine Learning Framework for Risk-Benefit Optimization — Europe PMC PMID:42591699 — Europe PMC (en), https://europepmc.org/article/MED/42591699 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_65bcfe0857e4 (Metraipolis archive dc_65bcfe0857e4, sha256 71cb173501fe3f03fbec58c35f3cd2b52aa3acea93addd36a1f162949aa45305)
BibTeX
@misc{dc65bcfe0857e4,
title = {Personalizing Maintenance Rituximab in Follicular Lymphoma: A Machine Learning Framework for Risk-Benefit Optimization — Europe PMC PMID:42591699},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42591699},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_65bcfe0857e4; sha256 71cb173501fe3f03fbec58c35f3cd2b52aa3acea93addd36a1f162949aa45305},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42591699. Agents can read the archived copy with the MCP tool read_document.